etoposide has been researched along with Fibrosarcoma in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (12.12) | 18.7374 |
| 1990's | 16 (48.48) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, D; Hu, Y; Li, S; Xiong, D; Yagüe, E; Yan, C; Yang, M; Zhang, Y; Zhou, Y | 1 |
| Aljarbou, AN; Alorainy, MS; Alsharidah, MS; Khan, MA; Maswadeh, HM | 1 |
| Aljarbou, AN; Alorainy, MS; Khan, MA; Maswadeh, HM; Rahmani, AH | 1 |
| Baba, J; Ichikawa, K; Igarashi, N; Ishikawa, D; Kagamu, H; Kondo, R; Koshio, J; Koya, T; Miura, S; Nakata, K; Narita, I; Nozaki, K; Okajima, M; Saida, Y; Sato, K; Shoji, S; Tanaka, J; Tanaka, T; Watanabe, S; Yoshizawa, H | 1 |
| Brünner, N; Lademann, UA; Larsen, L; Offenberg, H; Rømer, MU | 1 |
| Cook, JL; Iklé, DN; Lewis, AM; Miura, TA; Routes, JM | 1 |
| Beljin, M; Clifford, B; Stark, GR; Taylor, WR | 1 |
| Hashimoto, C; Masui, S; Naito, M; Tsuruo, T | 1 |
| Brünner, N; Christensen, IJ; Hofland, KF; Jensen, PB; Lademann, U; Larsen, L; Rømer, MU | 1 |
| Acquaviva, AM; Acquaviva, F; Di Matola, T; di Palma, A; Leone, V; Matarese, G; Ricchi, P | 1 |
| De Bruyne, GK; Dragonetti, CH; Mareel, MM; Van Cauwenberge, RM | 1 |
| Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z | 1 |
| Benchokroun, Y; Larsen, AK; Lelièvre, S | 1 |
| Craft, AW; Davies, SM; Jones, PH; King, DJ; Kynaston, JA; Malcolm, AJ; Mitchell, CD; Oakhill, A; Stiller, CA | 1 |
| Cotter, TG; Samali, A | 1 |
| Hoyt, DG; Johnson, CS; Lazo, JS; Mannix, RJ; Modzelewski, RA; Rusnak, JM | 1 |
| Armin, G; Axenovich, SA; Boiko, AD; Gudkov, AV; Kazarov, AR; Roninson, IB | 1 |
| Adhikari, D; Banerjee, D; Bertino, JR; Fu, JZ; Schnieders, B; Zhao, SC | 1 |
| Bernaert, D; Del Bino, G; Galand, P; Horman, S; Mairesse, N; Mosselmans, R; Robaye, B | 1 |
| Gardner, RV; Shetty, AK; Warrier, RP; Yu, LC | 1 |
| Kojima, T; Naruse, T; Tokunaga, Y | 1 |
| Chandra, S; Gupta, SK; Kochupillai, V; Sengupta, S; Tyagi, P | 1 |
| Jacobson, EL; Katschinski, DM; Robins, HI; Wiedemann, GJ | 1 |
| Mashima, T; Tsuruo, T; Udagawa, S | 1 |
| Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T | 1 |
| Chan, D; Doroshow, JH; Hinds, M; Mayes, J; Meltzer, PS; Parker, E; Sie, KL; Slovak, ML; Trent, JM; Zwelling, LA | 1 |
| Dezube, B; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
| Branellec, D; Chouaib, S; Markovits, J | 1 |
| al-Achi, A; Herman, TS; Holden, SA; Pfeffer, MR; Teicher, BA | 1 |
| al-Achi, A; Herman, TS; Holden, SA; Teicher, BA | 1 |
| Alexander, RB; Coffey, DS; Nelson, WG | 1 |
| Kuchiwaki, H; Mizuno, M; Shimosawa, S; Yoshida, J | 1 |
| Holden, SA; Rose, CM; Teicher, BA | 1 |
1 trial(s) available for etoposide and Fibrosarcoma
| Article | Year |
|---|---|
Role of chemotherapy in the treatment of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Soft Tissue Neoplasms; Vincristine | 1999 |
32 other study(ies) available for etoposide and Fibrosarcoma
| Article | Year |
|---|---|
Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aldehyde Dehydrogenase 1 Family; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Calcium-Binding Proteins; CD24 Antigen; Cell Movement; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Isoenzymes; Lung Neoplasms; MCF-7 Cells; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Retinal Dehydrogenase; RNA Interference; RNA, Small Interfering; Spheroids, Cellular; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2014 |
Etoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camelus; Diffusion; Drug Synergism; Etoposide; Female; Fibrosarcoma; Liposomes; Mice; Mice, Inbred BALB C; Milk; Phospholipids; Treatment Outcome | 2015 |
Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Combined Chemotherapy Protocols; Calorimetry, Differential Scanning; Camelus; Chemistry, Pharmaceutical; Doxorubicin; Etoposide; Female; Fibrosarcoma; Immunoenzyme Techniques; Liposomes; Mice; Mice, Inbred BALB C; Milk; Phospholipids; Sarcoma, Experimental | 2015 |
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.
Topics: Adoptive Transfer; Animals; Cisplatin; Cyclophosphamide; Cytotoxins; Deoxycytidine; Drug Resistance; Etoposide; Female; Fibrosarcoma; Gemcitabine; Lymph Nodes; Lymphocyte Depletion; Lymphopenia; Methylcholanthrene; Mice; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Vidarabine; Whole-Body Irradiation | 2015 |
Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Chromones; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Fibrosarcoma; Mice; Morpholines; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; RNA, Small Interfering; Serpin E2; Serpins; Signal Transduction; Transfection; Tumor Cells, Cultured | 2008 |
E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Topics: Adenovirus E1A Proteins; Adenoviruses, Human; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Etoposide; Female; Fibrosarcoma; Genes, p53; Humans; Immunologic Surveillance; Kidney; Killer Cells, Natural; Mice; Mice, Nude; Oncogenes; Osteosarcoma; Rats; Rats, Nude; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2003 |
G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Topics: Caffeine; CDC2 Protein Kinase; Cyclin B; Cyclin B1; Down-Regulation; Drug Interactions; Enzyme Inhibitors; Etoposide; Fibrosarcoma; G2 Phase; Humans; Mitosis; Thiobarbiturates; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Caspase-independent necrotic cell death induced by a radiosensitizer, 8-nitrocaffeine.
Topics: Antibodies, Monoclonal; Antimycin A; Caffeine; Caspases; Cell Death; Cell Hypoxia; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Drug Resistance, Multiple; Etoposide; fas Receptor; Fibrosarcoma; Free Radical Scavengers; HL-60 Cells; Humans; Jurkat Cells; K562 Cells; Necrosis; Radiation-Sensitizing Agents; Reactive Oxygen Species; U937 Cells; Xanthines | 2004 |
Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Fibrosarcoma; Lung Neoplasms; Male; Mice; Plasminogen Activator Inhibitor 1 | 2005 |
Aspirin reduces the outcome of anticancer therapy in Meth A-bearing mice through activation of AKT-glycogen synthase kinase signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Aspirin; Etoposide; Female; Fibrosarcoma; Glycogen Synthase Kinases; Methylcholanthrene; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors; Tumor Cells, Cultured | 2006 |
Glycosylated podophyllotoxin congeners: loss of microtubule inhibition and permission of invasion in vitro.
Topics: Animals; Cell Division; Chick Embryo; Etoposide; Fibrosarcoma; Mice; Microtubules; Myocardium; Organ Culture Techniques; Podophyllotoxin; Teniposide | 1982 |
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fibrosarcoma; Floxuridine; Humans; Liposarcoma; Methotrexate; Molecular Sequence Data; Oligonucleotide Probes; Osteosarcoma; Recombinant Proteins; Retinoblastoma Protein; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transfection; Tumor Cells, Cultured | 1995 |
Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
Topics: Amsacrine; Animals; Camptothecin; Cell Nucleus; Cricetinae; Cricetulus; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; Doxorubicin; Drug Resistance; Etoposide; Fibrosarcoma; Lung Neoplasms; Neoplasm Proteins; Suramin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1995 |
Chemotherapy in the management of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Karyotyping; Leg; Male; Remission Induction; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 1993 |
Heat shock proteins increase resistance to apoptosis.
Topics: Animals; Apoptosis; Camptothecin; Cell Line; Cell Survival; Dactinomycin; DNA Damage; Etoposide; Fibrosarcoma; Heat-Shock Proteins; Heat-Shock Response; Humans; Mice; Monocytes; Tumor Cells, Cultured | 1996 |
Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.
Topics: Animals; Antibodies; Antigens, CD; Basement Membrane; Cell Adhesion; Cell Survival; Cells, Cultured; DNA Damage; Endothelium, Vascular; Etoposide; Extracellular Matrix Proteins; Fibronectins; Fibrosarcoma; Gelatin; Integrin alpha5; Integrin beta1; Integrin beta3; Integrins; Laminin; Lipopolysaccharides; Mice; Mice, Inbred C3H; Oligopeptides; Platelet Membrane Glycoproteins | 1996 |
Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Chromosome Mapping; Colchicine; DNA, Complementary; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Fibrosarcoma; Gout Suppressants; Humans; Kinesins; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Suppression, Genetic; Transfection; Tumor Cells, Cultured | 1998 |
Role of E2F-1 in chemosensitivity.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Survival; Cloning, Molecular; Culture Media, Serum-Free; DNA-Binding Proteins; Doxorubicin; E2F Transcription Factors; E2F1 Transcription Factor; Etoposide; Fibrosarcoma; Humans; Irinotecan; Paclitaxel; Recombinant Proteins; Retinoblastoma-Binding Protein 1; Tetrahydrofolate Dehydrogenase; Transcription Factor DP1; Transcription Factors; Transfection; Tumor Cells, Cultured | 1998 |
Expression of HSP27 results in increased sensitivity to tumor necrosis factor, etoposide, and H2O2 in an oxidative stress-resistant cell line.
Topics: Actins; Animals; Cell Division; Cytoskeleton; Drug Resistance; Etoposide; Fibrosarcoma; Heat-Shock Proteins; Hot Temperature; Humans; Hydrogen Peroxide; Mice; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Osteoblasts; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Antitumor effect of oxycellulose as a hemostatic during operation.
Topics: Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; DNA, Neoplasm; Erythrocytes; Etoposide; Female; Fibrosarcoma; Hemostatics; Hypromellose Derivatives; Injections, Intraperitoneal; Liver Neoplasms, Experimental; Methylcellulose; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mitomycin; Tumor Cells, Cultured | 1998 |
Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blood Platelets; Body Weight; Capsules; Etoposide; Fibrosarcoma; Leukocytes; Liposomes; Male; Mice; Random Allocation | 2001 |
Modulation of VP-16 cytotoxicity by carboplatin and 41.8 degrees C hyperthermia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Carboplatin; Cell Survival; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Etoposide; Fibrosarcoma; Hyperthermia, Induced; Mice; NAD; Time Factors; Tumor Cells, Cultured | 2001 |
Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.
Topics: Activating Transcription Factor 3; Active Transport, Cell Nucleus; Amino Acid Chloromethyl Ketones; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Camptothecin; Caspase Inhibitors; Caspases; Enzyme Activation; Enzyme Inhibitors; Etoposide; Fibrosarcoma; Gene Expression Regulation; HeLa Cells; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Topoisomerase I Inhibitors; Transcription Factors; Transfection; Tumor Cells, Cultured | 2001 |
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine | 1992 |
HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
Topics: Amsacrine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Catalase; Cell Line; Cell Nucleus; DNA Probes; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Etoposide; Fibrosarcoma; Glucosephosphate Dehydrogenase; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Humans; Kinetics; Membrane Glycoproteins; Neoplasm Proteins; Superoxide Dismutase; Topoisomerase II Inhibitors | 1990 |
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Fibrosarcoma; Hematopoietic Stem Cells; Indazoles; Male; Melphalan; Mice; Mice, Inbred C3H; Pentoxifylline; Sarcoma, Experimental | 1991 |
Potentiation of TNF-mediated cell killing by VP-16: relationship to DNA single-strand break formation.
Topics: Animals; Cell Survival; Dexamethasone; DNA Damage; DNA, Neoplasm; DNA, Single-Stranded; Drug Synergism; Etoposide; Fibrosarcoma; Mice; Quinacrine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |
The interaction of cisplatin plus etoposide with radiation +/- hyperthermia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Survival; Cisplatin; Combined Modality Therapy; Etoposide; Fibrosarcoma; Flow Cytometry; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiotherapy Dosage | 1990 |
Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Survival; Cyclophosphamide; Drug Combinations; Etoposide; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Male; Melphalan; Mice; Mice, Inbred C3H; Organoplatinum Compounds | 1990 |
Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.
Topics: Animals; Bleomycin; Cell Line; Cell Survival; Cytarabine; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Drug Synergism; Etoposide; Fibrosarcoma; Glycoproteins; Hydroxyurea; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha | 1987 |
[Intracranial fibrosarcoma fifteen years after radiotherapy in bilateral retinoblastomas: effect of combined chemotherapy with cisplatin and VP-16].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Eye Neoplasms; Fibrosarcoma; Frontal Lobe; Humans; Male; Neoplasms, Radiation-Induced; Orbital Neoplasms; Radiotherapy; Retinoblastoma | 1989 |
Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carbon Dioxide; Cell Line; Cell Survival; Drug Combinations; Drug Interactions; Etoposide; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Oxygen; Podophyllotoxin; Tumor Stem Cell Assay | 1985 |